Since 1986 when we first opened, Boston IVF's ground-breaking research has contributed to improvements in assisted reproductive technologies and fertility treatment. Patients at Boston IVF benefit from working with the same experts who conducted these studies; when appropriate, patients are invited to participate in these research studies as well. Below are brief descriptions of two studies currently being conducted by Boston IVF. The FORTT and ISIS trials are performed in affiliation with Harvard Medical School, Dartmouth College and Beth Israel Deaconess Medical Center (BIDMC) and are funded by the National Institutes of Health (NIH). the primary Federal agency for conducting medical research.

FASTT TRIAL: Now completed. The FASTT trial was the largest-ever funded trial by the National Institutes of Health (NIH) in the field of infertility. The purpose of this randomized prospective clinical trial was to determine whether an infertility treatment that moves quickly to In Vitro Fertilization (IVF) is more cost effective than the usual treatment strategy which includes various combinations of infertility drugs and intrauterine insemination (IUI) prior to utilizing In Vitro Fertilization.

ISIS STUDY: The purpose of this study is to evaluate the link between lifestyle and fertility. This study is currently recruiting women age 20-34 and their male partners who are planning their first pregnancy. Click here for more information on this trial.

FORTT (Forty and Over Infertility Treatment) Trial: This study will help determine the best treatment for infertile women over the age of 40. Visit the FORTT trial website for more information.

Additionally, Boston IVF initiates new research projects on a regular basis. If you are interested in enrolling in a study or learning more about our research, please speak with your Boston IVF physician or our Study Coordinator, Kristin B.